New therapeutic applications of ozenoxacin in superficial skin infections
In recent years, the incidence of community-acquired methicillin-resistant S. aureus skin infections (CA-MARSA) has increased in pediatric population without associated risk factors. Ozenoxacin 10mg/g is a topical quinolone that has shown high activity on strains of S. aureus, S. pyogenes and other...
Saved in:
Main Authors: | Gema García Ron (Author), María Villa Arranz (Author) |
---|---|
Format: | Book |
Published: |
PAGEPress Publications,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Green Nail Syndrome Treated with Ozenoxacin: Two Case Reports
by: Terenzio Cosio, et al.
Published: (2023) -
The Use of Ozenoxacin in Pediatric Patients: Clinical Evidence, Efficacy and Safety
by: Giusy Davino, et al.
Published: (2020) -
Safety and efficacy profile of ozenoxacin 1% cream in pediatric patients with impetigo
by: Adelaide A. Hebert, MD, et al.
Published: (2020) -
Superficial angiomyxoma of the skin
by: Alvaro Abarzúa-Araya, et al.
Published: (2016) -
Retrospective Analysis of the Real-World Use of Topical Antimicrobials in the Paediatric Population with Impetigo in Italy: Focus on the Role of Ozenoxacin 1% Cream
by: Elisa Barbieri, et al.
Published: (2023)